Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in advanced hepatocellular carcinoma
NCT01334112Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jan 2011
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in hepatocellular carcinoma (HCC), sponsored by University Health Network. Started Jan 2011; status: completed.
02
Drugs
axitinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01334112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01334112.